Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $138.92 +0.40%
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of goods sold: 1.13B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $2.14 billion versus the consensus estimate of $2.07 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
